ARDMQ
Aradigm
–
Index: OTC Markets; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 700.11K; Volume: 0.00; AvgVol 3m: 127.15K; Beta: 3.29;
Cost estimate:
P/E: –; EPS: -1.09; EPS growth quarter/prev quarter: –;
EPS growth this year: –; EPS growth past 5 years: –;
EPS ttm: –;
P/S: –; P/B: –; P/Cashflow: –; P/FCF: –;
Sales: –; Sales growth quarter/prev quarter: –; Sales growth past 5 years: –;
Profitability:
Gross Margin: –; Profit Margin: –; Operating Margin: –;
ROA – return on assets: –; ROE – return on equity: –; LT Debt/Equity: –; Total Debt/Equity: –;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: –; Insider Transactions:–;
Institutional Ownership: –; Institutional Transactions: –;
Data update: 07/10/2020.